- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
DCB-Based PCI safe and Improves Outcomes in High Bleeding Risk Patients, suggests study

Researchers have found in a new study that among patients with high bleeding risk, percutaneous coronary intervention using drug-coated balloons was associated with a significantly lower risk of major adverse cardiovascular events compared with treatment using drug-eluting stents alone. These findings indicate that drug-coated balloon-based percutaneous coronary intervention may be an effective and safer treatment strategy for improving clinical outcomes in patients with high bleeding risk.
Managing patients with high bleeding risk who require percutaneous coronary intervention remains challenging, and available data are limited. This study investigated the clinical outcomes of drug-coated balloon-based percutaneous coronary intervention compared with drug-eluting stent-only percutaneous coronary intervention in patients with high bleeding risk undergoing percutaneous coronary intervention. The investigators included 652 consecutive patients with high bleeding risk undergoing drug-coated balloon-based percutaneous coronary intervention and compared them with 652 propensity-matched patients who received conventional percutaneous coronary intervention with second-generation drug-eluting stents. Patients were followed for two years to assess major adverse cardiovascular events.
Results showed that baseline clinical characteristics were comparable between the groups. In the drug-coated balloon-based percutaneous coronary intervention group, 71.6 percent of patients were successfully treated with drug-coated balloon alone. Patients in the drug-coated balloon-based percutaneous coronary intervention group had lower cardiac mortality at two years compared with those in the drug-eluting stent-only group (2.0 percent versus 5.2 percent; hazard ratio 0.37; 95 percent confidence interval 0.18 to 0.74; p = 0.005). Rates of target vessel revascularization (2.5 percent versus 6.0 percent; hazard ratio 0.43; 95 percent confidence interval 0.24 to 0.78; p = 0.005) and major bleeding events (1.4 percent versus 5.4 percent; hazard ratio 0.26; 95 percent confidence interval 0.12 to 0.58; p = 0.001) were also lower with drug-coated balloon-based percutaneous coronary intervention than with drug-eluting stent-only percutaneous coronary intervention. Myocardial infarction events were comparable between the two groups. In a multivariable model, drug-coated balloon-based percutaneous coronary intervention was independently associated with a reduced risk of two-year cardiac death, target vessel revascularization, and major bleeding.
In patients with high bleeding risk, drug-coated balloon-based percutaneous coronary intervention was associated with a significantly lower risk of major adverse cardiovascular events compared with drug-eluting stent-only treatment. These findings suggest that drug-coated balloon-based percutaneous coronary intervention may be a viable treatment strategy for improving outcomes in patients with high bleeding risk.
Dr. Shravani Dali has completed her BDS from Pravara institute of medical sciences, loni. Following which she extensively worked in the healthcare sector for 2+ years. She has been actively involved in writing blogs in field of health and wellness. Currently she is pursuing her Masters of public health-health administration from Tata institute of social sciences. She can be contacted at editorial@medicaldialogues.in.
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751

